KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 124 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $42,000 | -78.2% | 12,660 | -75.2% | 0.00% | – |
Q2 2018 | $193,000 | -80.5% | 51,071 | -78.9% | 0.00% | – |
Q1 2018 | $990,000 | +254.8% | 242,200 | +302.3% | 0.00% | – |
Q4 2017 | $279,000 | +11.2% | 60,200 | +70.1% | 0.00% | – |
Q3 2017 | $251,000 | -50.7% | 35,382 | -49.8% | 0.00% | – |
Q2 2017 | $509,000 | +17.3% | 70,467 | 0.0% | 0.00% | – |
Q1 2017 | $434,000 | +1636.0% | 70,467 | +1254.4% | 0.00% | – |
Q1 2016 | $25,000 | -13.8% | 5,203 | -5.8% | 0.00% | – |
Q4 2015 | $29,000 | -78.2% | 5,522 | -85.3% | 0.00% | – |
Q3 2015 | $133,000 | +6550.0% | 37,558 | +18679.0% | 0.00% | – |
Q2 2015 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
Q1 2015 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2014 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q3 2014 | $3,000 | -91.9% | 200 | -91.8% | 0.00% | – |
Q2 2014 | $37,000 | +1133.3% | 2,430 | +1115.0% | 0.00% | – |
Q1 2014 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2013 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
Q3 2013 | $2,000 | 0.0% | 200 | -20.0% | 0.00% | – |
Q2 2013 | $2,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baupost Group | 18,300,000 | $258,945,000 | 5.09% |
EcoR1 Capital, LLC | 589,000 | $8,334,000 | 4.22% |
Camber Capital Management LP | 3,000,000 | $42,450,000 | 2.82% |
Cormorant Asset Management, LP | 1,000,000 | $14,150,000 | 2.18% |
SECTORAL ASSET MANAGEMENT INC | 3,257,358 | $46,092,000 | 2.07% |
Knoll Capital Management, LLC | 200,000 | $2,830,000 | 1.11% |
OAK RIDGE INVESTMENTS LLC | 3,247,990 | $45,959,000 | 1.10% |
NORTHPOINTE CAPITAL LLC | 514,445 | $7,279,000 | 0.87% |
Apex Capital Management | 1,843,754 | $26,089,000 | 0.70% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,183,484 | $16,746,000 | 0.60% |